Skp2 is required for incretin hormone-mediated β-cell proliferation

Molecular Endocrinology

Volumn 25, Issue 12, 2011, Pages 2134-2143

  Tschen, Shuen Ing ^a   Georgia, Senta ^a   Dhawan, Sangeeta ^a   Bhushan, Anil ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; INCRETIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P16; PROTEIN P27; S PHASE KINASE ASSOCIATED PROTEIN 2;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ADULT; AGE FACTORS; AGED; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P27; GENE KNOCKDOWN TECHNIQUES; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INCRETINS; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN-SECRETING CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; PEPTIDES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEOLYSIS; RNA INTERFERENCE; S-PHASE KINASE-ASSOCIATED PROTEINS; SIGNAL TRANSDUCTION; VENOMS;

EID: 82055191839     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2011-1119     Document Type: Article

References (33)

1. Brubaker PL, Drucker DJ 2004 Minireview: glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology 145:2653-2659
2. Holz GG, Chepurny OG 2005 Diabetes outfoxed by GLP-1? Sci STKE 2005:pe2
3. Tschen SI, Dhawan S, Gurlo T, Bhushan A 2009 Age-dependent decline in β cell proliferation restricts the capacity of β cell regeneration in mice. Diabetes 58:1312-1320
4. Jhala US, Canettieri G, Screaton RA, Kulkarni RN, Krajewski S, Reed J, Walker J, Lin X, White M, Montminy M 2003 cAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2. Genes Dev 17:1575-1580
5. Park S, Dong X, Fisher TL, Dunn S, Omer AK, Weir G, White MF 2006 Exendin-4 uses Irs2 signaling to mediate pancreatic β cell growth and function. J Biol Chem 281:1159-1168
6. Dor Y, Brown J, Martinez OI, Melton DA 2004 Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429:41-46
7. Georgia S, Bhushan A 2004 β cell replication is the primary mechanism for maintaining postnatal β cell mass. J Clin Invest 114:963-968
8. Georgia S, Bhushan A 2006 p27 Regulates the transition of β-cells from quiescence to proliferation. Diabetes 55:2950-2956
9. Montagnoli A, Fiore F, Eytan E, Carrano AC, Draetta GF, Hershko A, Pagano M 1999 Ubiquitination of p27 is regulated by Cdkdependent phosphorylation and trimeric complex formation. Genes Dev 13:1181-1189
10. Sheaff RJ, Groudine M, Gordon M, Roberts JM, Clurman BE 1997 Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev 11:1464-1478
11. Uchida T, Nakamura T, Hashimoto N, Matsuda T, Kotani K, Sakaue H, Kido Y, Hayashi Y, Nakayama KI, White MF, KasugaM 2005 Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. Nat Med 11: 175-182
12. Carrano AC, Eytan E, Hershko A, Pagano M 1999 SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1:193-199
13. Sutterlü ty H, Chatelain E, Marti A, Wirbelauer C, Senften M, Mü ller U, Krek W 1999 p45skp2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat Cell Biol 1:207-214
14. Zhong L, Georgia S, Tschen SI, Nakayama K, Nakayama K, Bhushan A 2007 Essential role of Skp2-mediated p27 degradation in growth and adaptive expansion of pancreatic β cells. J Clin Invest 117:2869-2876
15. Kulkarni RN, Holzenberger M, Shih DQ, Ozcan U, Stoffel M, Magnuson MA, Kahn CR 2002 β-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter β-cell mass. Nat Genet 31:111-115
16. Buteau J, Spatz ML, Accili D 2006 Transcription factor FoxO1 mediates glucagon-like peptide-1 effects on pancreatic β-cell mass. Diabetes 55:1190-1196
17. Song WJ, Schreiber WE, Zhong E, Liu FF, Kornfeld BD, Wondisford FE, Hussain MA 2008 Exendin-4 stimulation of cyclin A2 in β-cell proliferation. Diabetes 57:2371-2381
18. Hui H, Nourparvar A, Zhao X, Perfetti R 2003 Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway. Endocrinology 144:1444-1455
19. Tuttle RL, Gill NS, Pugh W, Lee JP, Koeberlein B, Furth EE, Polonsky KS, Naji A, Birnbaum MJ 2001 Regulation of pancreatic β-cell growth and survival by the serine/threonine protein kinase Akt1/PKBα. Nat Med 7:1133-1137
20. Chen H, Gu X, Su IH, Bottino R, Contreras JL, Tarakhovsky A, Kim SK 2009 Polycomb protein Ezh2 regulates pancreatic β-cell Ink4a/Arf expression and regeneration in diabetes mellitus. Genes Dev 23:975-985
21. Dhawan S, Tschen SI, Bhushan A 2009 Bmi-1 regulates the Ink4a/ Arf locus to control pancreatic β-cell proliferation. Genes Dev 23: 906-911
22. Krishnamurthy J, Ramsey MR, Ligon KL, Torrice C, Koh A, Bonner-Weir S, Sharpless NE 2006 p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 443:453-457
23. Rankin MM, Kushner JA 2009 Adaptive β-cell proliferation is severely restricted with advanced age. Diabetes 58:1365-1372
24. Xu G, Kaneto H, Lopez-Avalos MD, Weir GC, Bonner-Weir S 2006 GLP-1/exendin-4 facilitates β-cell neogenesis in rat and human pancreatic ducts. Diabetes Res Clin Pract 73:107-110
25. Matveyenko AV, Dry S, Cox HI, Moshtaghian A, Gurlo T, Galasso R, Butler AE, Butler PC 2009 Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin. Diabetes 58:1604-1615
26. Körner M, Stöckli M, Waser B, Reubi JC 2007 GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting. J Nucl Med 48:736-743
27. Singh G, Eng J, Raufman JP 1994 Use of 125I-[Y39]exendin-4 to characterize exendin receptors on dispersed pancreatic acini and gastric chief cells from guinea pig. Regul Pept 53:47-59
28. Ji P, Goldin L, Ren H, Sun D, Guardavaccaro D, Pagano M, Zhu L 2006 Skp2 contains a novel cyclin A binding domain that directly protects cyclin A from inhibition by p27Kip1. J Biol Chem 281: 24058-24069
29. Kossatz U, Dietrich N, Zender L, Buer J, Manns MP, Malek NP 2004 Skp2-dependent degradation of p27kip1 is essential for cell cycle progression. Genes Dev 18:2602-2607
30. Frouin I, Montecucco A, Biamonti G, Hü bscher U, Spadari S, Maga G 2002 Cell cycle-dependent dynamic association of cyclin/Cdk complexes with human DNA replication proteins. EMBO J 21: 2485-2495
31. Sherr CJ, Roberts JM 1999 CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512
32. Nachnani JS, Bulchandani DG, Nookala A, Herndon B, Molteni A, Pandya P, Taylor R, Quinn T, Weide L, Alba LM 2010 Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas. Diabetologia 53:153-159
33. Karamitopoulou E, Zlobec I, Tornillo L, Carafa V, Schaffner T, Brunner T, Borner M, Diamantis I, Zimmermann A, Terracciano L 2010 Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN). Pathology 42:229-234